Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886163-14-000067
Filing Date
2014-06-05
Accepted
2014-06-05 16:39:45
Documents
1
Period of Report
2014-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5657
  Complete submission text file 0000886163-14-000067.txt   7045
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11085 NORTH TORREY PINES RD., SUITE 300 LA JOLLA CA 92037
Business Address
Patel Sunil (Reporting) CIK: 0001503062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 14894093